Core Capabilities

25+ years’ experience in respiratory R&D previously working at Teva, Novartis and GSK. Led development of several of Teva’s Gx inhalation products from concept to commercialisation, established Teva’s IVIVC department and collaborated with FDA on inhaled bioequivalence requirements, and led a global programme for Teva’s Gx complex products (inhaled, injectables and ophthalmic) to redefine development strategy to achieve right first time product approvals

Qualifications

BSc (Hons) Pharmaceutical Science